FDA skeptical of benefits from experimental ALS drug
Federal health regulators issued a negative review Monday of a closely watched experimental drug for the debilitating illness known as Lou Gehrig's disease, after months of lobbying by patient advocates urging approval.
Mar 28, 2022
0
11
